The remarkable story behind the revolutionary miracle cure for cancer, Gleevec. Novartis chairman Dr Dan Vasella describes its development and how he and Novartis orchestrated the break-neck approval and massive production of this amazing drug. Pharmaceutical giant Novartis recently developed Gleevec, one of the first 'smart' drugs created to kill cancer cells without damaging healthy cells in the process. In early tests with a common form of leukemia...
Related Subjects
Allied Health Services Basic Sciences Biography & History Business Business & Finance Business & Investing Clinical Company Profiles Internal Medicine Management Management & Leadership Marketing Marketing & Sales Medical Medical Books Medicine Oncology Pharmacology Pharmacy Product Development